Holistic Preferences for 1-Year Health Profiles Describing Fluctuations in Health: The Case of Chronic Obstructive Pulmonary Disease

Author： Mölken Maureen P.M.H. Rutten-van Hoogendoorn Martine Lamers Leida M.

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.27, Iss.6, 2009-06, pp. : 465-477

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

By Doll Helen

PharmacoEconomics, Vol. 23, Iss. 4, 2005-01 ,pp. : 345-363

Adis International

Access to resources Recommend Favorite

A 1-Year Prospective Cost-Effectiveness Analysis of Roflumilast for the Treatment of Patients with Severe Chronic Obstructive Pulmonary Disease

By Mölken Maureen P.M.H. Rutten-van

PharmacoEconomics, Vol. 25, Iss. 8, 2007-01 ,pp. : 695-711

Adis International

Access to resources Recommend Favorite

Do health-status measures play a role in improving treatment in chronic obstructive pulmonary disease?

By van der Molen Thys Kocks Jan Willem H

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 1, 2006-01 ,pp. : 57-61

Informa Healthcare

Access to resources Recommend Favorite

Indacaterol: In Chronic Obstructive Pulmonary Disease

By Moen Marit D.

Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. : 2269-2280

Adis International

Access to resources Recommend Favorite

Roflumilast: In Chronic Obstructive Pulmonary Disease

By Sanford Mark

Drugs, Vol. 70, Iss. 12, 2010-08 ,pp. : 1615-1627

Adis International

Access to resources Recommend Favorite